Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level
Helicobacter · 2024
DOI: 10.1111/hel.13063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Helicobacter, 2024. Verfasst von Chen Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Henan University People's Hospital, and Henan Provincial People's Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Cost-Benefit Analysis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health Commission of Henan Province, Health Commission of Henan Province-Research Innovative Talents Project.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Background
The overall benefits of the newly introduced family‐based Helicobacter pylori ( H. pylori ) infection control and management (FBCM) and screen‐and‐treat strategies in preventing multiple upper gastrointestinal diseases at national level in China have not been explored. We investigate the cost‐effectiveness of these strategies in the whole Chinese population. Materials and Methods Decision trees and Markov models of H. pylori infection‐related non‐ulcer dyspepsia (NUD), peptic ulcer disease (PUD), and gastric cancer (GC) were developed to simulate the cost‐effectiveness of these strategies in the whole 494 million households in China. The main outcomes include cost‐effectiveness, life years (LY), quality‐adjusted life year (QALY), and incremental cost‐effectiveness ratio (ICER).
Results
When compared with no‐screen strategy, both FBCM and screen‐and‐treat strategies reduced the number of new cases of NUD, PUD, PUD‐related deaths, and the prevalence of GC, and cancer‐related deaths. The costs saved by these two strategies were $1467 million and $879 million, quality‐adjusted life years gained were 227 million and 267 million, and life years gained were 59 million and 69 million, respectively. Cost‐effectiveness analysis showed that FBCM strategy costs −$6.46/QALY and −$24.75/LY, and screen‐and‐treat strategy costs −$3.3/QALY and −$12.71/LY when compared with no‐screen strategy. Compared to the FBCM strategy, the screen‐and‐treat strategy reduced the incidence of H. pylori ‐related diseases, added 40 million QALYs, and saved 10 million LYs, but at the increased cost of $588 million. Cost‐effectiveness analysis showed that screen‐and‐treat strategy costs $14.88/QALY and $59.5/LY when compared with FBCM strategy. The robustness of the results was also verified.
Conclusions
Both FBCM and screen‐and‐treat strategies are highly cost‐effective in preventing NUD, PUD, and GC than the no‐screen strategy in Chinese families at national level. As FBCM strategy is more practical and efficient, it is expected to play a more important role in preventing familial H. pylori infection and also serves as an excellent reference for other highly infected societies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Henan University People's Hospital, and Henan Provincial People's Hospital, Zhengzhou, China.
- Department of Gastroenterology and Hepatology, People's Hospital of Zhengzhou University, and Henan Provincial People's Hospital, Zhengzhou, China.
- Department of Gastroenterology and Hepatology, Huangchuan People's Hospital, Huangchuan, China.
- Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong Univers…
Förderung
- National Natural Science Foundation of China
- Health Commission of Henan Province
- Health Commission of Henan Province-Research Innovative Talents Project
- Shanghai Sailing Program
Zitieren
APA
Zhang, C., Qi, Y. B., Hu, R. B., Xu, L., Li, X. T., Ma, J., Shao, Q. Q., Abdun, M. A., Ur Rahman, I., Shi, W. J., Li, F. Q., Yu, J. J., Yuan, M. K., Chen, Q., Lu, H., & Ding, S. Z. (2024). Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level. Helicobacter. https://doi.org/10.1111/hel.13063
Vancouver
Zhang C, Qi YB, Hu RB, Xu L, Li XT, Ma J, et al. Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level. Helicobacter. 2024. doi:10.1111/hel.13063
BibTeX
@article{Zhang2024,
author = {Zhang, Chen and Qi, Ya-Bin and Hu, Ruo-Bing and Xu, Lu and Li, Xiao-Ting and Ma, Jing and Shao, Qiao-Qiao and Abdun, Mohammed Awadh and Ur Rahman, Ishtiaq and Shi, Wen-Jun and Li, Fu-Qiang and Yu, Jian-Jie and Yuan, Ming-Kai and Chen, Qi and Lu, Hong and Ding, Song-Ze},
title = {Family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are highly cost‐effective in preventing multiple upper gastrointestinal diseases in Chinese population at national level},
journal = {Helicobacter},
year = {2024},
doi = {10.1111/hel.13063}
}
EUVIMED